39 results
S-3ASR
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
shares that it beneficially owns, subject to applicable community property laws. Applicable percentages are based on 265,853,807 shares outstanding
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
, third-party payors and others in the medical community necessary for commercial success.
Even if we obtain approvals from the FDA, the European … and others in the medical community on the benefits of our products, if approved, may require significant resources and may never be successful
424B5
AUTL
Autolus Therapeutics plc
9 Feb 24
Prospectus supplement for primary offering
5:15pm
) the impact of the company’s operations on the community and the environment, (v) the desirability to maintain a reputation for high standards
S-3ASR
AUTL
Autolus Therapeutics plc
7 Feb 24
Automatic shelf registration
10:00pm
with suppliers, customers and others, (iv) the impact of the company’s operations on the community and the environment, (v) the desirability to maintain
8-K
AUTL
Autolus Therapeutics plc
11 Dec 23
Regulation FD Disclosure
8:31am
and presentations to the investment community to provide updates and summaries of its business. On December 10, 2023, the Company conducted an event
424B5
ngd5w9axu
9 Dec 22
Prospectus supplement for primary offering
5:40pm
424B5
44s0rljaxmavjxlo
8 Dec 22
Prospectus supplement for primary offering
4:10pm
6-K
EX-1
ezdgwen0 eo9kwyeww
1 Jul 22
Current report (foreign)
5:15pm
424B3
wmhqnz5 5bt
18 May 22
Prospectus supplement
4:09pm
F-3
gm7h0qhhkq
3 May 22
Shelf registration (foreign)
7:25pm
424B3
av1fimvpfw
3 May 22
Prospectus supplement
4:55pm
F-3
oe5vhg2ffknzhto3ynu3
14 Apr 22
Shelf registration (foreign)
9:30pm
6-K
EX-99.3
udlerxdn7td90jkxj7x
8 Nov 21
Securities Purchase Agreement
5:28pm
424B5
g63a64t9smy0uq3r
19 Aug 21
Prospectus supplement for primary offering
4:13pm
F-3
pgjo22kyzytbnud
6 Aug 21
Shelf registration (foreign)
2:30pm
6-K
EX-1
hwtbwyrp xfk1235kg
30 Jun 21
Annual Report and Accounts
6:05am
424B5
y1hhmndf6ydp629obh
11 Feb 21
Prospectus supplement for primary offering
5:16pm